Tumor necrosis factor-alpha polymorphism and secretion in myasthenia gravis

Chinese Medical Sciences Journal

Volumn 20, Issue 2, 2005, Pages 104-107

  Guan, Yu Zhou ^a   Cui, Li Ying ^a   Li, Yan Feng ^a   Zhang, Jun Bao ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Allele; Myasthenia gravis; Polymorphism; Tumor necrosis factor

Indexed keywords

CHOLINERGIC RECEPTOR; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; MYASTHENIA GRAVIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN POLYMORPHISM; PROTEIN SECRETION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 23044449385     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122-8.
2. Matsuki K, Juji T, Tokunaga K, et al. HLA antigens in Japanese patients with myasthenia gravis. J Clin Invest 1990;86:392-9.
3. Garchon HJ, Djabiri F, Viard JP, et al. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci USA 1994; 91:4668-72.
4. Skeie GO, Pandey JP, Aarli JA, et al. TNFA and TNFB polymorphisms in Myasthenia Gravis. Arch Neurol 1999;56:457-61.
5. Wilson AG, di Giovine FS, Blakemore AI, et al. Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353-5.
6. Heckmann JM, Morrison KE, Emeryk-Szajewska B, et al. Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J Autoimmun 1996;9:175-80.
7. Hjelmstrom P, Peacock SC, Giscombe R, et al. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region. Ann N Y Acad Sci 1998;841:368-70.
8. He B, Navikas V, Lundahl J, et al. Tumor necrosis factor α-308 alleles in multiple sclerosis and optic neuritis, J Neuroimmunol 1995;63:143-7.
9. Goluszko E, Hjelmstrom P, Deng C, et al. Lymphotoxin-alpha deficiency completely protects C57BL/6 mice from developing clinical experimental autoimmune myasthenia gravis. J Neuroimmunol 2001;113:109-18.
10. Goluszko E, Deng C, Poussin MA, et al. Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis. J Neuroimmunol 2002; 122:85-93.
11. Matusevicius D, Navikas V, Palasik W, et al. Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perform mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis. J Neuroimmunol 1996;71:191-8.
12. Bongioanni P, Ricciardi R, Pellergrino D, et al. T-cell tumor necrosis factor-alpha receptor binding in myasthenic patients. J Neuroimmuno 1999;93:203-7.